Other functions study/chemical-biological

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN261200900022I
Awardee
Awarding agency
Task orders
29 $1,395,385 obligated

Award facts

Combined order value
$1,478,658 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 27% used
$5,242,365.41
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Sterility assay, line item 119 units: each catalog#: 510120GMP.BSV HHSN26100033 National Cancer Institute (NIH) $36,008
Package 1, line item 94, sterility units: each catalog#: 510120GMP.BSV HHSN26100031 National Cancer Institute (NIH) $2,238
Sterility assay, line item 119 units: each catalog#: 510120GMP.BSV HHSN26100032 National Cancer Institute (NIH) $36,008
Sterility assay, line item 119 units: each catalog#: 510120GMP.BSV HHSN26100029 National Cancer Institute (NIH) $36,008
Package 1, line item 94, sterility catalog#: 510120GMP.BSV HHSN26100028 National Cancer Institute (NIH) $88,339
Other functions description: package 1, line item 94, sterility units: each catalog#: 510120GMP.BSV GSA schedule HHSN26100026 National Cancer Institute (NIH) $88,339
Other functions biosafety testing of GMP master cell banks and retroviral vectors option year 3 HHSN26100025 National Cancer Institute (NIH) $0
Other functions package 2, line item 88, sterility units: each catalog#: 510120GMP.BSV HHSN26100024 National Cancer Institute (NIH) $35,018
Package 2, line item 88, sterility units: each catalog#: 510120GMP.BSV HHSN26100023 National Cancer Institute (NIH) $35,018
Package 1, line item 63, sterility units: each catalog#: 510120GMP.BSV HHSN26100022 National Cancer Institute (NIH) $86,334
Package 1, line item 88, sterility units: each catalog#: 510011.BSV GSA schedule HHSN26100021 National Cancer Institute (NIH) $9,631
Package 1, line item 63, sterility units: each catalog#: 510036.BSV HHSN26100020 National Cancer Institute (NIH) $86,304
Package 1, line item 88, sterility units: each catalog#: 510011.BSV HHSN26100019 National Cancer Institute (NIH) $35,018
Biosafety testing of GMP master cell banks and retroviral vectors funding for option year 2 HHSN26100017 National Cancer Institute (NIH) $0
Package 1, line item 57, sterility, 510011.BSV HHSN26100016 National Cancer Institute (NIH) $33,781
Package 1, line item 32 sterlilty 510036.BSV HHSN26100015 National Cancer Institute (NIH) $83,273
PACKAGE1, line 35 catalog # 011600.BSV HHSN261200900022I maste cell bank HHSN26100014 National Cancer Institute (NIH) $6,312
Package 1, line item 57, sterility # 510011.BSV HHSN26100013 National Cancer Institute (NIH) $33,781
Option year 1 for contract HHSN261200900022I master cell bank testing. Package 1, line item 32, sterility # 510036.BSV HHSN26100012 National Cancer Institute (NIH) $83,273
Package 2, line item 57 sterility # 510011.BSV HHSN26100011 National Cancer Institute (NIH) $33,781
510036.BSV package 1, line item 32 sterility HHSN26100010 National Cancer Institute (NIH) $0
Biosafety testing of GMP master cell banks and retroviral vectors funding for option year 1 HHSN26100008 National Cancer Institute (NIH) $117,054
Package 1, line 1, sterility #510036.BSV HHSN26100007 National Cancer Institute (NIH) $73,108
Vector biosafety testing KDR vector supernatant/ item#26 assay# 510011.BSV sterility HHSN26100006 National Cancer Institute (NIH) $32,797
TAS::75 0849::tasvector biosafety testing mage-A3 vector supernatant item#26 assay#510011.BSV sterility HHSN26100005 National Cancer Institute (NIH) $32,797
26#510011.BSV sterility HHSN26100004 National Cancer Institute (NIH) $32,797
510000.BSV sterility HHSN26100003 National Cancer Institute (NIH) $161,696
Line#1 510000.BSV sterlilty HHSN26100002 National Cancer Institute (NIH) $80,848
Galv RCR (S=+/L-) line item#4 package#1 HHSN26100001 National Cancer Institute (NIH) $15,824
Show all 29

Transactions

Action Obligated Date
Exercise an Option 8 · Other functions modification to exercise option $0
Other Administrative Action 7 · Other functions modification for administrative changes $0
Other Administrative Action 6 $0
Exercise an Option 5 $0
Other Administrative Action 4 · Modification for administrative changes $0
Other Administrative Action 3 · Administrative modification to add individuals authorized to process delivery / task orders $0
Exercise an Option 2 · Exercise option year 1 of contract $0
Other Administrative Action 1 · Study/chemical-biological $0
Original award $0

Quick answers

Who was awarded contract HHSN261200900022I?

HHSN261200900022I was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on July 1, 2009.

How much is contract HHSN261200900022I worth?

Orders under HHSN261200900022I have obligated $1,395,385. Their combined current value, with exercised options, is $1,478,658. HHSN261200900022I's own ceiling is $5,242,365.

How many orders have been placed under contract HHSN261200900022I?

29 orders have been placed under HHSN261200900022I, the latest on February 1, 2013.

Who can order from contract HHSN261200900022I?

HHSN261200900022I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN261200900022I competed?

The extent of competition for HHSN261200900022I was competed under sap. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login